Core Laboratories NV (CLB)

Currency in USD
10.64
+0.24(+2.31%)
Closed·
10.640.00(0.00%)
·
CLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.2210.79
52 wk Range
9.1320.36
Key Statistics
Prev. Close
10.64
Open
10.36
Day's Range
10.22-10.79
52 wk Range
9.13-20.36
Volume
880.17K
Average Volume (3m)
597.62K
1-Year Change
-33.2497%
Book Value / Share
6.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.00
Upside
+40.98%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Core Laboratories NV News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

2 Buy
0 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 15.00
(+40.98% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Johnson Rice
Buy21.00+97.37%-UpgradeAug 13, 2026

Core Laboratories NV Earnings Call Summary for Q3/2026

  • Core Labs reported Q3 2026 EPS of $0.12, missing Wall Street's $0.32 forecast by 62.5%, though revenue rose 6% sequentially to $132.1M.
  • Product sales surged 19% quarter-over-quarter while operating margin improved to 10% from 8%, with EBIT ex-items climbing 34% to $12.6M.
  • Middle East conflict and Russia-Ukraine disruptions continued delaying projects; management sees broader global recovery emerging in 2027.
  • Q4 guidance projects revenue of $128.5M-$134.5M and EPS of $0.12-$0.20, essentially flat with Q3 results at midpoint.
  • Shares fell 2.38% after-hours to $10.24, near 52-week low of $9.13; net debt stands at $93.4M with leverage under 1.5x.
Last Updated: 29/10/2026, 14:18
Read Full Transcript

Earnings

Latest Release
Oct 28, 2026
EPS / Forecast
0.12 / 0.32
Revenue / Forecast
132.1M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.34
Dividend Yield
0.38%
Industry Median 1.38%
Annualised payout
0.04
Paid quarterly
5-Years Growth
-
Growth Streak

CLB Income Statement

Compare CLB to Peers and Sector

Metrics to compare
CLB
Peers
Sector
Relationship
P/E Ratio
31.3x28.4x5.3x
PEG Ratio
−0.62−1.600.00
Price/Book
1.8x3.3x1.1x
Price / LTM Sales
0.9x2.1x1.4x
Upside (Analyst Target)
41.0%−3.9%26.0%
Fair Value Upside
Unlock−0.6%8.7%Unlock

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
23.35M50.88%248.41M
Other Institutional Investors
24.93M49.12%265.20M
Public Companies & Retail Investors
0.000.00%0.00
Total
48.27M100.00%513.62M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ariel Investments, LLC30.67%14,074,945149,757
Ariel Investment Trust - Ariel Fund14.11%6,474,66368,890

People Also Watch

78.00
PBF
+3.26%
1,150.89
SNDK
-13.47%
20.35
WY
+3.04%
149.03
JCI
-5.84%

FAQ

What Is the Core Laboratories (CLB) Stock Price Today?

The Core Laboratories stock price today is 10.64 USD.

What Stock Exchange Does Core Laboratories Trade On?

Core Laboratories is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Core Laboratories?

The stock symbol for Core Laboratories is "CLB."

What Is the Core Laboratories Market Cap?

As of today, Core Laboratories market cap is 487.56M USD.

What Is Core Laboratories's Earnings Per Share (TTM)?

The Core Laboratories EPS (TTM) is 0.34.

From a Technical Analysis Perspective, Is CLB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Core Laboratories Stock Split?

Core Laboratories has split 2 times.

How Many Employees Does Core Laboratories Have?

Core Laboratories has 3300 employees.

What is the current trading status of Core Laboratories (CLB)?

As of Nov 01, 2026, Core Laboratories (CLB) is trading at a price of 10.64 USD, with a previous close of 10.64 USD. The stock has fluctuated within a day range of 10.22 USD to 10.79 USD, while its 52-week range spans from 9.13 USD to 20.36 USD.

What Is Core Laboratories (CLB) Price Target According to Analysts?

The average 12-month price target for Core Laboratories is 15.00 USD, with a high estimate of 21 USD and a low estimate of 11 USD. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +40.98% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.